CLYM
Price
$1.21
Change
+$0.01 (+0.83%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
81.65M
46 days until earnings call
ELVN
Price
$19.86
Change
+$0.98 (+5.19%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
973.23M
35 days until earnings call
Ad is loading...

CLYM vs ELVN

Header iconCLYM vs ELVN Comparison
Open Charts CLYM vs ELVNBanner chart's image
Climb Bio
Price$1.21
Change+$0.01 (+0.83%)
Volume$2.12K
Capitalization81.65M
Enliven Therapeutics
Price$19.86
Change+$0.98 (+5.19%)
Volume$4.07K
Capitalization973.23M
CLYM vs ELVN Comparison Chart
Loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLYM vs. ELVN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Buy and ELVN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CLYM: $1.21 vs. ELVN: $19.86)
Brand notoriety: CLYM and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 42% vs. ELVN: 314%
Market capitalization -- CLYM: $81.65M vs. ELVN: $973.23M
CLYM [@Biotechnology] is valued at $81.65M. ELVN’s [@Biotechnology] market capitalization is $973.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than CLYM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 3 bullish TA indicator(s).

  • CLYM’s TA Score: 5 bullish, 3 bearish.
  • ELVN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLYM is a better buy in the short-term than ELVN.

Price Growth

CLYM (@Biotechnology) experienced а -6.92% price change this week, while ELVN (@Biotechnology) price change was -3.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

CLYM is expected to report earnings on May 19, 2025.

ELVN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($973M) has a higher market cap than CLYM($81.6M). ELVN YTD gains are higher at: -16.089 vs. CLYM (-33.333). CLYM has higher annual earnings (EBITDA): -24.57M vs. ELVN (-104.24M). ELVN has more cash in the bank: 313M vs. CLYM (193M). ELVN has less debt than CLYM: ELVN (0) vs CLYM (58K). CLYM (0) and ELVN (0) have equivalent revenues.
CLYMELVNCLYM / ELVN
Capitalization81.6M973M8%
EBITDA-24.57M-104.24M24%
Gain YTD-33.333-16.089207%
P/E RatioN/AN/A-
Revenue00-
Total Cash193M313M62%
Total Debt58K0-
TECHNICAL ANALYSIS
Technical Analysis
CLYMELVN
RSI
ODDS (%)
Bullish Trend 6 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLDRX9.470.02
+0.21%
BlackRock Managed Income K
MWEHX43.32N/A
N/A
MFS Global Equity R3
AGWUX53.51N/A
N/A
American Century Growth R5
EMAAX15.05N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
LCMRX36.52N/A
N/A
ClearBridge Mid Cap Growth R

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-1.64%
RLYB - CLYM
41%
Loosely correlated
-6.80%
LRMR - CLYM
31%
Poorly correlated
-6.98%
CLDX - CLYM
30%
Poorly correlated
-7.16%
ELVN - CLYM
30%
Poorly correlated
-4.07%
CMRX - CLYM
28%
Poorly correlated
-0.12%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with APGE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-4.07%
APGE - ELVN
46%
Loosely correlated
-4.68%
DNLI - ELVN
45%
Loosely correlated
-9.60%
CRNX - ELVN
44%
Loosely correlated
-8.71%
ERAS - ELVN
44%
Loosely correlated
-12.04%
ABOS - ELVN
42%
Loosely correlated
-2.27%
More